What’s Going On With Nvidia Tuesday?

Artificial intelligence kingpin Nvidia Corp (NASDAQ: NVDA) keeps hitting the headlines courtesy of the AI frenzy, Alphabet Inc (NASDAQ: GOOG) (NASDAQ:

Artificial intelligence kingpin Nvidia Corp (NASDAQ:NVDA) keeps hitting the headlines courtesy of the AI frenzy, Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOGL) being the latest tech juggernaut to notch up its AI offerings.

The ace chipmaker scaled higher since its upbeat second-quarter results and ambitious outlook made its previously steep valuation appear cheaper than its rivals.

However, the caveat seems to be Taiwan Semiconductor Manufacturing Company Ltd (NYSE:TSM) responsible for making Nvidia’s chips, the Financial Times reports. 

Also Read: Federal Appeals Court Rules For Grayscale In Spot Bitcoin ETF Case

TSMC’s second-quarter revenue declined despite the proportion of revenues from TSMC’s High-Performance Computing segment remaining essentially unchanged from the previous year.

Nvidia’s rapidly rising margins reflect its pricing power and dominant market share for the hottest graphics processing chips.

Nvidia’s premium AI processor, the H100, selling at steep premiums in the second-hand market, reflects the onslaught of the supply crisis.

Also, concerns loom due to China’s tense geopolitical relations with Taiwan, especially with the U.S. tightening sanctions on the former.

Meanwhile, Nvidia’s rivals also kicked off their strategies to tap the AI frenzy. 

Advanced Micro Devices, Inc (NASDAQ: AMD) remains focused on Radeon RX 7800 and RX 7700 series graphics cards launch.

Microsoft Corp (NASDAQ: MSFT) backed OpenAI showcased its corporate-focused ChatGPT Enterprise to cater to a diverse business clientele.

Also, Intel Corp (NASDAQ:INTC) shared plans about a next-generation data center chip likely for a 2024 launch. The chip promises to provide over double the computational capability amid global efforts to reduce energy consumption. 

Price Action: NVDA shares traded higher by 3.35% at $484.02 on the last check Tuesday.

Total
0
Shares
Related Posts
Read More

As Global Recession Looms, These 3 Dividend Kings Are Primed To Benefit From The Sale Of Necessities

With the SPDR S&P 500 (ARCA: SPY) down roughly 22.5% year-to-date, investors may want to turn to blue chip dividend kings. These stocks typically lose less of their value than other stocks in the S&P 500 and increase dividends for 50 consecutive years.

KMB

Read More

Independent Data Monitoring Committee Completed Its Prespecified Review Of Interim Safety Data In Phio Pharmaceuticals’s Phase 1B Trial Of Ph-762 For Advanced Melanoma, Recommending The Study To Continue Without Modification.

PH-762 is an INTASYL compound that reduces the expression of cell death Protein 1 (PD-1), a protein that inhibits T cells' ability to kill cancer cells. Decreasing the expression of PD-1 increases the capacity of T

PHIO